Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 17, 2023
The
hallmark
of
acute
respiratory
distress
syndrome
(ARDS)
pathobiology
is
unchecked
inflammation-driven
diffuse
alveolar
damage
and
alveolar-capillary
barrier
dysfunction.
Currently,
therapeutic
interventions
for
ARDS
remain
largely
limited
to
pulmonary-supportive
strategies,
there
an
unmet
demand
pharmacologic
therapies
targeting
the
underlying
pathology
in
patients
suffering
from
illness.
complement
cascade
(ComC)
plays
integral
role
regulation
both
innate
adaptive
immune
responses.
ComC
activation
can
prime
overzealous
cytokine
storm
tissue/organ
damage.
lung
injury
(ALI)
have
established
relationship
with
early
maladaptive
activation.
In
this
review,
we
collected
evidence
current
studies
linking
ALI/ARDS
dysregulation,
focusing
on
elucidating
new
emerging
roles
extracellular
(canonical)
intracellular
(non-canonical
or
complosome),
(complementome)
pathobiology,
highlighting
complementome
as
a
vital
nexus
pathobiological
connectome
via
its
crosstalking
other
systems
immunome,
DAMPome,
PAMPome,
coagulome,
metabolome,
microbiome.
We
also
discussed
diagnostic/therapeutic
potential
future
direction
care
ultimate
goal
better
defining
mechanistic
subtypes
(endotypes
theratypes)
through
methodologies
order
facilitate
more
precise
effective
complement-targeted
therapy
treating
these
comorbidities.
This
information
leads
support
anti-inflammatory
strategy
by
ComC,
where
arsenal
clinical-stage
complement-specific
drugs
available,
especially
due
COVID-19.
Journal of Clinical Investigation,
Journal Year:
2020,
Volume and Issue:
130(11), P. 6151 - 6157
Published: Aug. 6, 2020
Emerging
data
indicate
that
complement
and
neutrophils
contribute
to
the
maladaptive
immune
response
fuels
hyperinflammation
thrombotic
microangiopathy,
thereby
increasing
coronavirus
2019
(COVID-19)
mortality.
Here,
we
investigated
how
interacts
with
platelet/neutrophil
extracellular
traps
(NETs)/thrombin
axis,
using
COVID-19
specimens,
cell-based
inhibition
studies,
NET/human
aortic
endothelial
cell
(HAEC)
cocultures.
Increased
plasma
levels
of
NETs,
tissue
factor
(TF)
activity,
sC5b-9
were
detected
in
patients.
Neutrophils
patients
yielded
high
TF
expression
released
NETs
carrying
active
TF.
Treatment
control
platelet-rich
generated
TF-bearing
induced
activity
HAECs.
Thrombin
or
NETosis
C5aR1
blockade
attenuated
platelet-mediated
NET-driven
thrombogenicity.
serum
activation
vitro,
consistent
clinical
samples.
Complement
C3
compstatin
Cp40
disrupted
neutrophils.
In
conclusion,
provide
a
mechanistic
basis
for
pivotal
role
immunothrombosis.
This
study
supports
strategies
against
severe
acute
respiratory
syndrome
2
exploit
inhibition.
Journal of Molecular Histology,
Journal Year:
2020,
Volume and Issue:
51(6), P. 613 - 628
Published: Oct. 4, 2020
The
outbreak
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV2)
in
December
2019
form
Wuhan,
China
leads
to
disease
(COVID-19)
pandemic.
While
the
common
cold
symptoms
are
observed
mild
cases,
COVID-19
is
accompanied
by
multiorgan
failure
patients.
involvement
different
organs
patients
results
lengthening
hospitalization
duration
and
increasing
mortality
rate.
In
this
review,
we
aimed
investigate
patients,
particularly
cases.
Also,
tried
define
potential
underlying
mechanisms
SARS-CoV2
induced
failure.
multi-organ
dysfunction
characterized
lung
failure,
liver
kidney
injury,
cardiovascular
disease,
as
well
a
wide
spectrum
hematological
abnormalities
neurological
disorders.
most
important
related
direct
indirect
pathogenic
features
SARS-CoV2.
Although
presence
angiotensin-converting
enzyme
2,
receptor
lung,
heart,
kidney,
testis,
liver,
lymphocytes,
nervous
system
was
confirmed,
there
controversial
findings
about
observation
RNA
these
organs.
Moreover,
organ
may
be
cytokine
storm,
result
increased
levels
inflammatory
mediators,
endothelial
dysfunction,
coagulation
abnormalities,
infiltration
cells
into
Therefore,
further
investigations
needed
detect
exact
pathogenesis.
Since
several
for
clinicians,
their
knowledge
help
improve
outcomes
decrease
rate
morbidity.
JCI Insight,
Journal Year:
2020,
Volume and Issue:
5(15)
Published: June 18, 2020
Coronavirus
disease
2019
(COVID-19),
the
caused
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
has
resulted
in
a
global
pandemic
and
disruptive
health
crisis.
COVID-19-related
morbidity
mortality
have
been
attributed
to
an
exaggerated
immune
response.
The
role
of
complement
activation
its
contribution
illness
severity
is
being
increasingly
recognized.
Here,
we
summarize
current
knowledge
about
interaction
coronaviruses
with
system.
We
posit
that
(a)
activate
multiple
pathways;
(b)
COVID-19
clinical
features
often
resemble
complementopathies;
(c)
combined
effects
activation,
dysregulated
neutrophilia,
endothelial
injury,
hypercoagulability
appear
be
intertwined
drive
COVID-19;
(d)
subset
patients
may
genetic
predisposition
associated
dysregulation;
(e)
these
observations
create
basis
for
trials
inhibitors
life-threatening
illness.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(3), P. 1566 - 1566
Published: Jan. 26, 2024
The
complement
system
is
the
other
major
proteolytic
cascade
in
blood
of
vertebrates
besides
coagulation–fibrinolytic
system.
Among
three
main
activation
routes
complement,
lectin
pathway
(LP)
has
been
discovered
latest,
and
it
still
subject
intense
research.
Mannose-binding
(MBL),
collectins,
ficolins
are
collectively
termed
as
pattern
recognition
molecules
(PRMs)
LP,
they
responsible
for
targeting
LP
to
molecular
patterns,
e.g.,
on
bacteria.
MBL-associated
serine
proteases
(MASPs)
effectors,
while
proteins
(MAps)
have
regulatory
functions.
Two
protease
components,
MASP-1
MASP-2,
trigger
activation,
third
component,
MASP-3,
involved
function
alternative
(AP)
complement.
Besides
their
functions
within
system,
certain
components
secondary
(“moonlighting”)
functions,
embryonic
development.
They
also
contribute
coagulation,
some
might
tumor
suppressing
roles.
Uncontrolled
can
progression
many
diseases
(e.g.,
stroke,
kidney
diseases,
thrombotic
complications,
COVID-19).
In
most
cases,
implicated.
this
review,
we
summarize
history
pathway,
introduce
describe
its
regulation,
roles
cascade,
connections
direct
cellular
effects.
Special
emphasis
placed
disease
non-canonical
components.
Med,
Journal Year:
2024,
Volume and Issue:
5(3), P. 239 - 253.e5
Published: Feb. 15, 2024
BackgroundLong
COVID
encompasses
a
heterogeneous
set
of
ongoing
symptoms
that
affect
many
individuals
after
recovery
from
infection
with
SARS-CoV-2.
The
underlying
biological
mechanisms
nonetheless
remain
obscure,
precluding
accurate
diagnosis
and
effective
intervention.
Complement
dysregulation
is
hallmark
acute
COVID-19
but
has
not
been
investigated
as
potential
determinant
long
COVID.MethodsWe
quantified
series
complement
proteins,
including
markers
activation
regulation,
in
plasma
samples
healthy
convalescent
confirmed
history
SARS-CoV-2
age/ethnicity/sex/infection/vaccine-matched
patients
COVID.FindingsMarkers
classical
(C1s-C1INH
complex),
alternative
(Ba,
iC3b),
terminal
pathway
(C5a,
TCC)
were
significantly
elevated
COVID.
These
combination
had
receiver
operating
characteristic
predictive
power
0.794.
Other
proteins
regulators
also
quantitatively
different
between
Generalized
linear
modeling
further
revealed
clinically
tractable
just
four
these
markers,
namely
the
fragments
iC3b,
TCC,
Ba,
C5a,
0.785.ConclusionsThese
findings
suggest
biomarkers
could
facilitate
currently
available
inhibitors
be
used
to
treat
COVID.FundingThis
work
was
funded
by
National
Institute
for
Health
Research
(COV-LT2-0041),
PolyBio
Foundation,
UK
Dementia
Institute.
Thrombosis Research,
Journal Year:
2020,
Volume and Issue:
196, P. 143 - 151
Published: Aug. 27, 2020
A
Severe
Acute
Respiratory
Syndrome-Coronavirus-2
(SARS-CoV-2)
has
become
a
pandemic
disease
named
Coronavirus
Disease-19
(COVID-19)
of
epochal
dimension.
The
clinical
spectrum
COVID-19
is
wide,
ranging
from
asymptomatic
forms
to
severe
pneumonia,
sepsis
and
multiple
organ
dysfunction
syndromes
resulting
in
poor
outcomes.
Among
the
various
consequences
COVID-19,
cardiovascular
(CV)
collapse
appears
most
serious
potentially
lethal.
On
other
hand,
pre-existent
CV
comorbidities
are
also
associated
with
higher
mortality.
reliable
hypothetical
pathogenetic
mechanism
for
complications
cardiac
injury
patients
be
sustained
endothelial
dysfunction,
caused
by
interplay
inflammation
coagulation.
In
this
review,
we
survey
papers
addressing
issues
related
characterized
enhanced
lung
microvascular
loss,
hypercytokinemia,
hypoxemia
thrombosis.
We
discuss
about
how
virus-induced
downregulation
angiotensin
converting
enzyme-2
(ACE2)
receptor,
used
enter
host
cell,
could
affect
renin-angiotensin
system,
attempting
clarify
doubts
use
ACE
inhibitors
Angiotensin-II
receptor
blockers
patients.
Finally,
point
out
delicate
physiological
homeostatic
function
endothelium,
which
turns
into
disastrous
battlefield
complex
interaction
between
"cytokine
coagulative
storms",
can
irreparably
compromised
result
systemic
inflammatory
complications.
Molecular Therapy,
Journal Year:
2022,
Volume and Issue:
30(5), P. 1869 - 1884
Published: Feb. 14, 2022
The
SARS-CoV-2
virus,
the
pathogen
causing
COVID-19,
has
caused
more
than
200
million
confirmed
cases,
resulting
in
4.5
deaths
worldwide
by
end
of
August,
2021.
Upon
detection
infection
pattern
recognition
receptors
(PRRs),
multiple
signaling
cascades
are
activated,
which
ultimately
leads
to
innate
immune
response
such
as
induction
type
I
and
III
interferons,
well
other
antiviral
genes
that
together
restrict
viral
spread
suppressing
different
steps
life
cycle.
Our
understanding
contribution
system
recognizing
subsequently
initiating
a
host
an
invasion
been
rapidly
expanding
from
2020.
Simultaneously,
evolved
evasion
strategies
escape
surveillance
for
successful
replication.
In
this
review,
we
will
address
current
knowledge
immunity
context
highlight
recent
advances
mechanisms
evades
host's
defense
system.
Archives of Microbiology & Immunology,
Journal Year:
2023,
Volume and Issue:
07(02)
Published: Jan. 1, 2023
Long
Covid
is
one
of
the
most
prevalent
and
puzzling
conditions
that
arose
with
pandemic.
Covid-19
infection
generally
resolves
within
several
weeks
but
some
experience
new
or
lingering
symptoms.
Though
there
no
formal
definition
for
such
symptoms
CDC
boadly
describes
long
as
persons
having
a
wide
range
new,
recurring
sustained
health
issues
four
more
after
first
being
infected
SARS-CoV2.
The
WHO
defines
manifestation
from
"probable
confirmed"
start
approximately
3
months
onset
acute
last
than
2
months.
Numerous
studies
have
looked
at
implications
on
various
organs.
Many
specific
mechanisms
been
proposed
changes.
In
this
article,
we
provide
an
overview
main
by
which
induces
end-organ
damage
in
recent
research
studies.
We
also
review
treatment
options,
current
clinical
trials,
other
potential
therapeutic
avenues
to
control
followed
information
about
effect
vaccination
Covid.
Lastly,
discuss
questions
knowledge
gaps
present
understanding
believe
effects
has
quality
life,
future
life
expectancy
are
required
better
understand
eventually
prevent
treat
disease.
acknowledge
not
limited
those
article
it
may
affect
offspring
therefore,
deem
important
identify
prognostic
targets
condition.
Immunobiology,
Journal Year:
2023,
Volume and Issue:
228(3), P. 152393 - 152393
Published: May 1, 2023
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
virus
was
identified
in
China
2019
as
the
causative
agent
of
COVID-19,
and
quickly
spread
throughout
world,
causing
over
7
million
deaths,
which
occurred
prior
to
introduction
first
vaccine.
In
following
discussion,
while
recognising
that
complement
is
just
one
many
players
we
focus
on
relationship
between
COVID-19
disease,
with
limited
digression
into
directly-related
areas
such
complement,
kinin
release,
coagulation.
Prior
outbreak,
an
important
role
for
diseases
had
been
established.
Subsequently,
multiple
investigations
patients
confirmed
dysregulation
likely
be
a
major
driver
disease
pathology,
some,
if
not
all,
patients.
These
data
fuelled
evaluation
complement-directed
therapeutic
agents
small
patient
cohorts,
claims
significant
beneficial
effect.
As
yet,
these
early
results
have
reflected
larger
clinical
trials,
posing
questions
who
treat,
appropriate
time
duration
treatment,
optimal
target
treatment.
While
control
pandemic
has
achieved
through
global
scientific
medical
effort
comprehend
etiology
extensive
SARS-CoV-2
testing
quarantine
measures,
vaccine
development,
improved
therapy,
possibly
aided
by
attenuation
dominant
strains,
it
yet
over.
this
review,
summarise
complement-relevant
literature,
emphasise
its
main
conclusions,
formulate
hypothesis
involvement
COVID-19.
Based
make
suggestions
how
any
future
outbreak
might
better
managed
order
minimise
impact